You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intravenous Chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Esophageal arterial infusion chemo, Systemic intravenous

Not yet recruiting
  • Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
  • Esophageal arterial infusion chemotherapy
  • Systemic intravenous chemotherapy
  • (no location specified)
May 15, 2022

Unresectable Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Unresectable Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    Beijing Friendship Hospital
Aug 17, 2022

Stage IV Gastric Cancer With Metastasis Trial (Camrelizumab; Nab-paclitaxel; S-1)

Not yet recruiting
  • Stage IV Gastric Cancer With Metastasis
  • Camrelizumab; Nab-paclitaxel; S-1
  • (no location specified)
Jul 5, 2022

Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Transcatheter arterial chemoembolization
  • +3 more
  • (no location specified)
Feb 17, 2022

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma Trial in United States (Pemetrexed, Cisplatin,

Recruiting
  • Malignant Peritoneal Mesothelioma
  • +4 more
  • Chicago, Illinois
  • +10 more
Sep 21, 2023

Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)

Recruiting
  • Hyperthermic Intraperitoneal Chemotherapy
  • Neoadjuvant Chemotherapy
  • HIPEC
  • intravenous chemotherapy
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Feb 17, 2022

Gastric Adenocarcinoma, Gastric Cancer, Esophagogastric Junction Trial run by the NCI (Paclitaxel, Capecitabine, BardPort

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Colon Cancer, Chemotherapeutic-Induced Anemia Trial (iron (isomaltoside), Dried Ferrous Sulfate)

Not yet recruiting
  • Colon Cancer
  • Chemotherapeutic-Induced Anemia
  • iron (isomaltoside)
  • Dried Ferrous Sulfate
  • (no location specified)
Mar 18, 2022

Pain, Fear Needles, Satisfaction, Patient Trial (Vascular imaging)

Not yet recruiting
  • Pain
  • +2 more
  • Vascular imaging
  • (no location specified)
Jun 6, 2023

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
Has Results
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Colorectal Cancer Trial (anesthetic method)

Withdrawn
  • Colorectal Cancer
  • anesthetic method
  • (no location specified)
Jul 11, 2023

Retinoblastoma Trial in China (Conbercept ophthalmic injection)

Recruiting
  • Retinoblastoma
  • Conbercept ophthalmic injection
  • Beijing, Beijing, China
  • +4 more
Jul 27, 2021

Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

Recruiting
  • Lung Squamous Cell Carcinoma
  • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
  • Yancheng, Jiangsu, China
    Yancheng Clinical College of Xuzhou Medical University
Mar 21, 2023

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

Cancer of Stomach, GastroEsophageal Cancer Trial in Pavia (Nutritional counseling alone, Early supplemental parenteral nutrition

Recruiting
  • Cancer of Stomach
  • GastroEsophageal Cancer
  • Nutritional counseling alone
  • Early supplemental parenteral nutrition plus nutritional counseling
  • Pavia, Italy
    Fondazione IRCCS Policlinico San Matteo
May 4, 2022

Cord Trial in Jinan (Intravenous infusion of cord blood mononuclear cells, application of granulocyte stimulating factor)

Recruiting
  • Cord
  • Intravenous infusion of cord blood mononuclear cells
  • application of granulocyte stimulating factor
  • Jinan, Shandong, China
    Pediatrics, Qianfoshan Hospital
Nov 25, 2022

Bladder Cancer Trial in Fairway, Kansas City (Ascorbic Acid)

Active, not recruiting
  • Bladder Cancer
  • Ascorbic Acid
  • Fairway, Kansas
  • +2 more
Sep 21, 2022

Metastatic NSCLC Trial (Pembrolizumab coformulated with hyaluronidase, Pemetrexed, Cisplatin)

Not yet recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Pembrolizumab coformulated with hyaluronidase
  • +6 more
  • (no location specified)
Jan 27, 2023

Retinoblastoma Trial in Seoul (Nitroglycerin, Normal saline)

Recruiting
  • Retinoblastoma
  • Seoul, Korea, Republic of
    Jin-Tae Kim
Jun 2, 2022

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Telisotuzumab Vedotin
  • +4 more
  • (no location specified)
Oct 17, 2023

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Neuroendocrine Neoplasms
  • BI 764532
  • +3 more
  • (no location specified)
Nov 10, 2023